PEPG PEPGEN INC

PepGen to Participate in the 22nd Annual Needham Virtual Healthcare Conference

PepGen to Participate in the 22nd Annual Needham Virtual Healthcare Conference

BOSTON, April 13, 2023 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that James McArthur, Ph.D., President and CEO of PepGen will present at the 22nd Annual Needham Virtual Healthcare Conference on Thursday, April 20th at 8:00am EDT.

The event will be webcast live under the  section of the  section of PepGen’s website. A replay of the event will be archived for one year.

About PepGen

PepGen Inc. is a clinical-stage biotechnology company advancing the next-generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. PepGen’s Enhanced Delivery Oligonucleotide, or EDO, platform is founded on over a decade of research and development and leverages cell-penetrating peptides to improve the uptake and activity of conjugated oligonucleotide therapeutics. Using these EDO peptides, we are generating a pipeline of oligonucleotide therapeutic candidates that target the root cause of serious diseases.

Investor Contact

Laurence Watts

Gilmartin Group

  

Media Contact

Sarah Sutton

Argot Partners



EN
13/04/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PEPGEN INC

Laura Chico
  • Laura Chico
Dylan Shindler ... (+2)
  • Dylan Shindler
  • Laura Chico
Dylan Shindler ... (+2)
  • Dylan Shindler
  • Laura Chico

ResearchPool Subscriptions

Get the most out of your insights

Get in touch